Reijo is a clinical pharmacologist specialized in cardiovascular pharmacology. Reijo spent more than six years at the Clinical Research Institute of Montreal and at the Laboratory of Experimental Neurology, ULB, Brussels as a post-doctoral fellow and visiting scientist. Prior to joining Zora Reijo has worked as Chief Research Scientist at Viikki Drug Discovery Technology Center, Helsinki and served as a consultant for pharmaceutical and biotechnology companies. Reijo is co-inventor of several patents and has published over 100 original scientific articles. Reijo is also research professor at Tampere University and medical director of the Finnish Clinical Biobank Tampere. Reijo’s interest in cardiovascular disease prevention and his experience in statin intolerance work are key assets for the development of the Zora porfolio. Reijo is a clinical pharmacologist specialized in cardiovascular pharmacology. Reijo spent more than six years at the Clinical Research Institute of Montreal and at the Laboratory of Experimental Neurology, ULB, Brussels as a post-doctoral fellow and visiting scientist. Prior to joining Zora Reijo has worked as Chief Research Scientist at Viikki Drug Discovery Technology Center, Helsinki and served as a consultant for pharmaceutical and biotechnology companies. Reijo is co-inventor of several patents and has published over 100 original scientific articles. Reijo is also research professor at Tampere University and medical director of the Finnish Clinical Biobank Tampere. Reijo’s interest in cardiovascular disease prevention and his experience in statin intolerance work are key assets for the development of the Zora porfolio.

cardiovascular pharmacology